Pivotal bioVenture Partners Investment Advisor as of Sept. 30, 2023
Portfolio Holdings for Pivotal bioVenture Partners Investment Advisor
Pivotal bioVenture Partners Investment Advisor holds 13 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Karuna Therapeutics Ord | 53.8 | $135M | 797k | 169.09 | |
| Vaxcyte (PCVX) | 16.1 | $40M | 793k | 50.98 | |
| Oculis Holding Ordinary Shares (OCS) | 9.7 | $24M | 2.2M | 11.00 | |
| Inozyme Pharma (INZY) | 7.5 | $19M | 4.5M | 4.20 | |
| Rallybio Corp (RLYB) | 3.2 | $8.1M | 2.4M | 3.37 | |
| Arcutis Biotherapeutics (ARQT) | 2.3 | $5.9M | 1.1M | 5.31 | |
| Fusion Pharmaceuticals | 1.6 | $4.1M | 1.6M | 2.60 | |
| Gracell Biotechnologies Sponsored Ads | 1.6 | $4.0M | 1.4M | 2.88 | |
| Exscientia Ads (EXAI) | 1.4 | $3.5M | 771k | 4.52 | |
| Vigil Neuroscience (VIGL) | 1.2 | $3.0M | 561k | 5.39 | |
| Bolt Biotherapeutics (BOLT) | 0.8 | $2.0M | 1.9M | 1.04 | |
| Io Biotech (IOBT) | 0.5 | $1.2M | 864k | 1.41 | |
| Aligos Therapeutics (ALGS) | 0.2 | $555k | 743k | 0.75 |
